Comparison of Mean Overall Survival (OS) and Radiographic Progression Free Survival (RPFS) Based on Matching Adjusted Indirect Comparison of Abiraterone Acetate and Enzalutamide for the Treatment of Castration-Resistant Prostate Cancer in C ...
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2170
https://www.valueinhealthjournal.com/article/S1098-3015(14)04100-X/fulltext
Title :
Comparison of Mean Overall Survival (OS) and Radiographic Progression Free Survival (RPFS) Based on Matching Adjusted Indirect Comparison of Abiraterone Acetate and Enzalutamide for the Treatment of Castration-Resistant Prostate Cancer in C ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04100-X&doi=10.1016/j.jval.2014.08.2170
First page :
A616
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1634